Researcher verification

This website offers reference compounds supplied strictly as Research Use Only (RUO) materials for in‑vitro laboratory research. Please confirm the following to enter:

Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration.

Research Only — Not For Human ConsumptionResearch Use Only
Fast & Discreet US ShippingAccredited US Lab TestedcGMP · ISO · ≥99% Purity
USDEUREN1
Tirzepatide (GLP-1/GIP) — Cintavia research peptide vial

Tirzepatide (GLP-1/GIP)

46.41€ – 158.01€

plus shipping

Dual GIP / GLP-1 receptor agonist. Lyophilized, ≥99% HPLC. COA available.

Specifications
Purity
≥99% HPLC
CAS
2023788-19-2
Formula
C225H348N48O68
Mol. weight
4813.5 g/mol
Form
Lyophilized
Storage
Store dry at −20°C; 2–8°C after reconstitution
View lab reports & COA →

Buy more, save more — 3+ vials −5% · 5+ −10% · 10+ −15% applied automatically at checkout.

● In stockShips in 2–4 business days · Free US shipping over $100
≥99% Purity GuaranteedFull Panel COAVerify authenticityShipping Protection IncludedSecure checkout
Category:
⚠ For Research Use Only. This product is supplied strictly as a Research Use Only (RUO) material for in-vitro laboratory research. Not for human or veterinary use, not for use in diagnostic procedures, and not evaluated by the U.S. Food and Drug Administration. Not a drug, food or dietary supplement. By purchasing you certify that you are at least 21 years of age and a qualified researcher, and will use the product for in-vitro research purposes only.
Purity (HPLC)≥99% HPLC
CAS Number2023788-19-2
Molecular FormulaC225H348N48O68
Molecular Weight4813.5 g/mol
Sequence39-aa dual GIP/GLP-1 receptor agonist
FormLyophilized
StorageStore dry at −20°C; 2–8°C after reconstitution

Certificate of Analysis

Every batch is independently tested by HPLC (purity), LC-MS (identity) and screened for endotoxins and heavy metals.

COA for this batch available on request.

Overview

Tirzepatide is a synthetic dual agonist of the GIP and GLP-1 receptors, supplied lyophilized for in-vitro incretin-signaling research.

Research background

Research literature has characterized dual GIP/GLP-1 receptor engagement and its downstream effects on insulin-secretion and metabolic endpoints in preclinical models.

All statements describe published third-party in-vitro / preclinical research only. Products are supplied strictly for laboratory research use — not for human or veterinary use.

Size

10 mg, 30 mg, 60 mg

Reviews

There are no reviews yet.

Be the first to review “Tirzepatide (GLP-1/GIP)”

Your email address will not be published. Required fields are marked *

Related products